Acronym
MoST 13 (substudy 31)
Project Title
A single-arm, open-label, phase II trial of entrectinib in patients with advanced tumours harbouring NTRK fusions or ROS1 gene rearrangements detected by comprehensive genomic profiling
Principal Investigator
Keywords
Cancer/NTRK fusions or ROS1 gene
Project Type
Interventional/Clinical trials research
